EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 343 filers reported holding EXELIXIS INC in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,000 | +33.3% | 242 | +70.4% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | -66.7% | 142 | -65.3% | 0.00% | – |
Q1 2021 | $9,000 | -99.8% | 409 | -99.8% | 0.00% | -100.0% |
Q2 2020 | $4,924,000 | +1569.2% | 207,432 | +1140.9% | 0.01% | +800.0% |
Q1 2020 | $295,000 | -13.7% | 16,716 | -13.8% | 0.00% | 0.0% |
Q4 2019 | $342,000 | +27.6% | 19,398 | +30.2% | 0.00% | – |
Q3 2019 | $268,000 | +3.1% | 14,903 | +22.5% | 0.00% | – |
Q2 2019 | $260,000 | -46.2% | 12,167 | -40.0% | 0.00% | -100.0% |
Q1 2019 | $483,000 | +22.6% | 20,276 | +1.2% | 0.00% | 0.0% |
Q4 2018 | $394,000 | -42.5% | 20,045 | -48.1% | 0.00% | 0.0% |
Q3 2018 | $685,000 | +11.2% | 38,635 | +38.9% | 0.00% | 0.0% |
Q1 2018 | $616,000 | -3.8% | 27,814 | +32.1% | 0.00% | 0.0% |
Q4 2017 | $640,000 | +91.6% | 21,048 | +52.7% | 0.00% | 0.0% |
Q3 2017 | $334,000 | – | 13,785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 16,484,638 | $501,133,000 | 64.50% |
Matrix Capital Management Company, LP | 10,000,000 | $304,000,000 | 10.86% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 410,334 | $12,470,000 | 4.40% |
Rhenman & Partners Asset Management AB | 756,214 | $22,989,000 | 3.11% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 703,049 | $21,372,000 | 1.57% |
Virtus ETF Advisers LLC | 36,522 | $1,110,000 | 1.39% |
PURA VIDA INVESTMENTS, LLC | 80,000 | $2,432,000 | 1.02% |
Crawford Lake Capital Management, LLC | 129,300 | $3,931,000 | 0.93% |
SMITH ASSET MANAGEMENT GROUP LP | 865,880 | $26,323,000 | 0.83% |
Crawford Lake Capital Management, LLC | 113,311 | $3,445,000 | 0.81% |